Loxo Oncology, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2014-05-12: Federal exemption Rule 506(b); Types of securities offered Equity; Series B Preferred Stock; Date of first sale 2014-04-24; Total offering amount $23,888,747.
- 2013-07-18: Federal exemption Rule 506; Types of securities offered Equity; Series A Preferred Stock; Date of first sale 2013-07-03; Total offering amount Indefinite.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2014-05-12 | Rule 506(b) | Equity; Series B Preferred Stock | 2014-04-24 | $23,888,747 | $23,888,747 | $0 | 7 |
| 2013-07-18 | Rule 506 | Equity; Series A Preferred Stock | 2013-07-03 | Indefinite | $10,000,000 | Indefinite | 2 |